Patients sue GLP-1 makers over sudden loss of vision
Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on thehill.com — the content belongs to The Hill.
